MAPT and tauopathy: Focusing on rodent studies, Kremer and colleagues analysed synaptosomes purified from the P301L tauopathy mouse model (which expresses the same mutation as in Tg4510 mice, but under a different promoter) and found an enrichment of AT8-positive tau in hippocampal synaptosomes (Kremer et al., 2011).